CIAM
ZVRA icon

Caitong International Asset Management’s Zevra Therapeutics ZVRA Stock Holding History

Caitong International Asset Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$923 Sell
99
-293
-75% -$2.64K ﹤0.01% 1460
2025
Q4 		$3.51K Buy
392
+197
+101% +$1.86K ﹤0.01% 1274
2025
Q3 		$1.85K Sell
195
-323
-62% -$3.24K ﹤0.01% 1394
2025
Q2 		$4.56K Sell
518
-77
-13% -$625 ﹤0.01% 1055
2025
Q1 		$4.46K Buy
+595
New +$4.73K ﹤0.01% 1049

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Caitong International Asset Management's ZVRA Position: Q1 2026 in Review

Caitong International Asset Management reduced its Zevra Therapeutics (ZVRA) stake by 75% in Q1 2026, selling an estimated $2.64K and leaving 99 shares worth $923. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

Caitong International Asset Management first reported a position in ZVRA in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.56K in Q2 2025. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • Caitong International Asset Management held 99 shares of Zevra Therapeutics worth $923 as of Q1 2026.
  • Caitong International Asset Management sold 293 Zevra Therapeutics shares in Q1 2026, an estimated $2.64K.
  • Zevra Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1460 holding.
  • Caitong International Asset Management first reported a position in Zevra Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Zevra Therapeutics position peaked at $4.56K in Q2 2025.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.